845 related articles for article (PubMed ID: 26683259)
1. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of novel AP-1 and NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats.
El-Salhy M; Umezawa K
Int J Mol Med; 2016 Jun; 37(6):1457-64. PubMed ID: 27082818
[TBL] [Abstract][Full Text] [Related]
3. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone.
Takeiri M; Tachibana M; Kaneda A; Ito A; Ishikawa Y; Nishiyama S; Goto R; Yamashita K; Shibasaki S; Hirokata G; Ozaki M; Todo S; Umezawa K
Inflamm Res; 2011 Sep; 60(9):879-88. PubMed ID: 21625968
[TBL] [Abstract][Full Text] [Related]
5. Brugia malayi cystatin therapeutically ameliorates dextran sulfate sodium-induced colitis in mice.
Khatri V; Amdare N; Tarnekar A; Goswami K; Reddy MV
J Dig Dis; 2015 Oct; 16(10):585-94. PubMed ID: 26358507
[TBL] [Abstract][Full Text] [Related]
6. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
7. Remission Effects of Dietary Soybean Isoflavones on DSS-Induced Murine Colitis and an LPS-Activated Macrophage Cell Line.
Kim SE; Kawaguchi K; Hayashi H; Furusho K; Maruyama M
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31362418
[TBL] [Abstract][Full Text] [Related]
8. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice.
Nishimura T; Andoh A; Nishida A; Shioya M; Koizumi Y; Tsujikawa T; Fujiyama Y
World J Gastroenterol; 2008 Oct; 14(38):5851-6. PubMed ID: 18855984
[TBL] [Abstract][Full Text] [Related]
9. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
10. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.
Hayashi S; Hamada T; Zaidi SF; Oshiro M; Lee J; Yamamoto T; Ishii Y; Sasahara M; Kadowaki M
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G968-78. PubMed ID: 25258409
[TBL] [Abstract][Full Text] [Related]
11. Potential role for ET-2 acting through ETA receptors in experimental colitis in mice.
Claudino RF; Leite DF; Bento AF; Chichorro JG; Calixto JB; Rae GA
Inflamm Res; 2017 Feb; 66(2):141-155. PubMed ID: 27778057
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Ohkawara T; Nishihira J; Takeda H; Hige S; Kato M; Sugiyama T; Iwanaga T; Nakamura H; Mizue Y; Asaka M
Gastroenterology; 2002 Jul; 123(1):256-70. PubMed ID: 12105854
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide.
Koide N; Kaneda A; Yokochi T; Umezawa K
Int Immunopharmacol; 2015 Mar; 25(1):162-8. PubMed ID: 25617668
[TBL] [Abstract][Full Text] [Related]
14. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice.
Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK
J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
Shen C; Dillissen E; Kasran A; Lin Y; Clydesdale G; Sienaert I; Jonghe SD; Gao LJ; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
J Interferon Cytokine Res; 2006 Aug; 26(8):575-82. PubMed ID: 16881868
[TBL] [Abstract][Full Text] [Related]
16. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells.
Nishitani Y; Yamamoto K; Yoshida M; Azuma T; Kanazawa K; Hashimoto T; Mizuno M
Biofactors; 2013; 39(5):522-33. PubMed ID: 23460110
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.
Peng XD; Wu XH; Chen LJ; Wang ZL; Hu XH; Song LF; He CM; Luo YF; Chen ZZ; Jin K; Lin HG; Li XL; Wang YS; Wei YQ
J Pharmacol Exp Ther; 2010 Jan; 332(1):46-56. PubMed ID: 19828878
[TBL] [Abstract][Full Text] [Related]
18. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
19. 4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization.
Jang HM; Kang GD; Van Le TK; Lim SM; Jang DS; Kim DH
Int Immunopharmacol; 2017 Apr; 45():90-97. PubMed ID: 28189973
[TBL] [Abstract][Full Text] [Related]
20. GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway.
Zhao Y; Sun Y; Ding Y; Wang X; Zhou Y; Li W; Huang S; Li Z; Kong L; Guo Q; Lu N
Oncotarget; 2015 Sep; 6(28):26291-307. PubMed ID: 26327408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
